Tetrabenazine Completed Phase 3 Trials for Tardive Dyskinesia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01543321Xenazine in Late Dyskinetic Syndrome With Neuroleptics